- Home
- ATO vs ILMN Comparison
ATO vs ILMN Comparison
Compare ATO & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATO
- ILMN
- Stock Information
- Founded
- ATO 1906
- ILMN 1998
- Country
- ATO United States
- ILMN United States
- Employees
- ATO N/A
- ILMN N/A
- Industry
- ATO Oil/Gas Transmission
- ILMN Medical Specialities
- Sector
- ATO Utilities
- ILMN Health Care
- Exchange
- ATO Nasdaq
- ILMN Nasdaq
- Market Cap
- ATO 24.4B
- ILMN 13.1B
- IPO Year
- ATO 1987
- ILMN 2000
- Fundamental
- Price
- ATO $154.09
- ILMN $97.15
- Analyst Decision
- ATO Buy
- ILMN Buy
- Analyst Count
- ATO 9
- ILMN 17
- Target Price
- ATO $157.94
- ILMN $124.35
- AVG Volume (30 Days)
- ATO 731.3K
- ILMN 2.4M
- Earning Date
- ATO 08-06-2025
- ILMN 07-31-2025
- Dividend Yield
- ATO 2.25%
- ILMN N/A
- EPS Growth
- ATO 8.10
- ILMN N/A
- EPS
- ATO 7.25
- ILMN N/A
- Revenue
- ATO $4,485,994,000.00
- ILMN $4,337,000,000.00
- Revenue This Year
- ATO $13.32
- ILMN N/A
- Revenue Next Year
- ATO $12.92
- ILMN $3.15
- P/E Ratio
- ATO $21.35
- ILMN N/A
- Revenue Growth
- ATO 10.60
- ILMN N/A
- 52 Week Low
- ATO $119.90
- ILMN $68.70
- 52 Week High
- ATO $167.45
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- ATO 51.05
- ILMN 59.14
- Support Level
- ATO $150.51
- ILMN $95.09
- Resistance Level
- ATO $156.61
- ILMN $101.28
- Average True Range (ATR)
- ATO 2.32
- ILMN 3.31
- MACD
- ATO 0.28
- ILMN -0.27
- Stochastic Oscillator
- ATO 61.99
- ILMN 58.10
About ATO Atmos Energy Corporation
Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.